Press Release

Back to News

Science Amplified

NZ bioscience celebrates its innovators

At the Annual NZ Bio award dinner, Wednesday night 23rd September, Dr Shivali Gulab was announced the Young Bioscientist of the Year.

At the Annual NZ Bio award dinner, Wednesday night 23rd September, Dr Shivali Gulab was announced the Young Bioscientist of the Year.

The Young Scientist of the Year, Dr Shivali is the CEO of Avalia Immunotherapies (Avalia). She helped establish Avalia, which is commercialising a novel, synthetic vaccine technology – the work of Ferrier, the Malaghan Institute of Medical Research and the University of Otago. The vaccine technology allows it to target a specific cancer or infectious disease. It is scalable, easily manufactured and complementary to other modes of treatment such as cancer immunotherapies.

NZ Bio CEO, Dr Will Barker, says the platform is at pre-clinical stage, but Avalia’s work has been published in world leading journals, such as Nature Chemical Biology and Chemical Science, and is attracting international attention.

Earlier this year Dr Gulab was selected to participate in the prestigious NYC Entrepreneurship Lab training programme and Avalia was awarded a National & Global Innovation Award at the 2015 TechConnect World Innovation Conference.

Click to view original article at NZ Bio

October, 2015 –

1

Back to top

© 2015 Avalia Immunotherapies

Webiste design & development
Wink Brand Design